3hon MSNOpinion
The Fed cut rates. Biotech didn’t notice.
Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. The report contains a ...
Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering. Fully revised and ...
The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.
Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...
Innovative Pharmaceutical Biotech (HK:0399) has released an update. Innovative Pharmaceutical Biotech Limited has entered into a Memorandum of Understanding to potentially acquire a majority stake in ...
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the ...
During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding the state’s life science and biotechnology research industry.
A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results